Invention Grant
- Patent Title: Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
- Patent Title (中): β阻断剂用于制造用于治疗血管瘤的药物的用途
-
Application No.: US13678902Application Date: 2012-11-16
-
Publication No.: US09173858B2Publication Date: 2015-11-03
- Inventor: Christine Leaute-Labreze , Eric Dumas De La Roque , Alain Taieb , Jean-Benoit Thambo
- Applicant: UNIVERSITE VICTOR SEGALEN-BORDEAUX 2
- Applicant Address: FR Bordeaux FR Talence
- Assignee: Universite de Bordeaux,Centre Hospitalier Universitaire de Bordeaux
- Current Assignee: Universite de Bordeaux,Centre Hospitalier Universitaire de Bordeaux
- Current Assignee Address: FR Bordeaux FR Talence
- Agency: Harness, Dickey & Pierce, P.L.C.
- Priority: EP07291273 20071019
- Main IPC: A61K31/00
- IPC: A61K31/00 ; A61K31/18 ; A61K31/138 ; A61K31/222 ; A61K31/36 ; A61K31/404 ; A61K31/4045 ; A61K31/4704 ; A61K31/5377
Abstract:
The present technology relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for example of infantile hemangiomas. The beta blocker may be a non-selective beta-blocker, for example propranolol. The present technology provides an alternative to the known compounds, e.g. corticosteroids, interferon or vincristine, generally used for the treatment of hemangiomas.
Public/Granted literature
- US20130072551A1 USE OF A BETA BLOCKER FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HEMANGIOMAS Public/Granted day:2013-03-21
Information query
